107 related articles for article (PubMed ID: 1610357)
1. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity.
Eugster HP; Bärtsch S; Würgler FE; Sengstag C
Biochem Biophys Res Commun; 1992 Jun; 185(2):641-7. PubMed ID: 1610357
[TBL] [Abstract][Full Text] [Related]
2. Functional expression of fused enzymes between human cytochrome P4501A1 and human NADPH-cytochrome P450 oxidoreductase in Saccharomyces cerevisiae.
Wittekindt NE; Würgler FE; Sengstag C
DNA Cell Biol; 1995 Apr; 14(4):273-83. PubMed ID: 7710684
[TBL] [Abstract][Full Text] [Related]
3. High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH-cytochrome P-450 reductase.
Sengstag C; Eugster HP; Würgler FE
Carcinogenesis; 1994 May; 15(5):837-43. PubMed ID: 8200084
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
5. Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes. Simulation of the two first steps of benzo[a]pyrene activation.
Gautier JC; Urban P; Beaune P; Pompon D
Eur J Biochem; 1993 Jan; 211(1-2):63-72. PubMed ID: 8425552
[TBL] [Abstract][Full Text] [Related]
6. Expression of human cytochromes P450 1A1 and P450 1A2 as fused enzymes with yeast NADPH-cytochrome P450 oxidoreductase in transgenic tobacco plants.
Shiota N; Kodama S; Inui H; Ohkawa H
Biosci Biotechnol Biochem; 2000 Oct; 64(10):2025-33. PubMed ID: 11129571
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA.
Yamada T; Imaishi H; Oka A; Ohkawa H
Biosci Biotechnol Biochem; 1998 Jul; 62(7):1403-11. PubMed ID: 9720224
[TBL] [Abstract][Full Text] [Related]
8. Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.
Hayashi K; Sakaki T; Kominami S; Inouye K; Yabusaki Y
Arch Biochem Biophys; 2000 Sep; 381(1):164-70. PubMed ID: 11019832
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol is a selective human cytochrome P450 1A1 inhibitor.
Chun YJ; Kim MY; Guengerich FP
Biochem Biophys Res Commun; 1999 Aug; 262(1):20-4. PubMed ID: 10448061
[TBL] [Abstract][Full Text] [Related]
10. Role of acidic residues in the interaction of NADPH-cytochrome P450 oxidoreductase with cytochrome P450 and cytochrome c.
Shen AL; Kasper CB
J Biol Chem; 1995 Nov; 270(46):27475-80. PubMed ID: 7499204
[TBL] [Abstract][Full Text] [Related]
11. In vivo reconstitution of highly active Candida maltosa cytochrome P450 monooxygenase systems in inducible membranes of Saccharomyces cerevisiae.
Zimmer T; Kaminski K; Scheller U; Vogel F; Schunck WH
DNA Cell Biol; 1995 Jul; 14(7):619-28. PubMed ID: 7626221
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a fusion protein between human cytochrome P450 1A1 and rat NADPH-P450 oxidoreductase in Escherichia coli.
Chun YJ; Jeong TC; Roh JK; Guengerich FP
Biochem Biophys Res Commun; 1997 Jan; 230(1):211-4. PubMed ID: 9020048
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of specifically active recombinant fused enzymes consisting of CYP3A4, NADPH-cytochrome P450 oxidoreductase, and cytochrome b5.
Inui H; Maeda A; Ohkawa H
Biochemistry; 2007 Sep; 46(35):10213-21. PubMed ID: 17691855
[TBL] [Abstract][Full Text] [Related]
15. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
16. A genetically engineered P450 monooxygenase: construction of the functional fused enzyme between rat cytochrome P450c and NADPH-cytochrome P450 reductase.
Murakami H; Yabusaki Y; Sakaki T; Shibata M; Ohkawa H
DNA; 1987 Jun; 6(3):189-97. PubMed ID: 3109864
[TBL] [Abstract][Full Text] [Related]
17. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
Buters JT; Shou M; Hardwick JP; Korzekwa KR; Gonzalez FJ
Drug Metab Dispos; 1995 Jul; 23(7):696-701. PubMed ID: 7587956
[TBL] [Abstract][Full Text] [Related]
18. Expression of CYP71B7, a cytochrome P450 expressed sequence Tag from Arabidopsis thaliana.
Maughan JA; Nugent JH; Hallahan DL
Arch Biochem Biophys; 1997 May; 341(1):104-11. PubMed ID: 9143359
[TBL] [Abstract][Full Text] [Related]
19. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae.
Sakaki T; Shibata M; Yabusaki Y; Murakami H; Ohkawa H
DNA Cell Biol; 1990 Oct; 9(8):603-14. PubMed ID: 2125425
[TBL] [Abstract][Full Text] [Related]
20. Xenobiotic metabolism in humanized yeast: engineered yeast cells producing human NADPH-cytochrome P-450 reductase, cytochrome b5, epoxide hydrolase and P-450s.
Urban P; Truan G; Gautier JC; Pompon D
Biochem Soc Trans; 1993 Nov; 21(4):1028-34. PubMed ID: 8131892
[No Abstract] [Full Text] [Related]
[Next] [New Search]
